Background: Survivors of herpes simplex encephalitis (HSE) commonly experience significant neurological sequelae, imposing a substantial burden on both society and families. The efficacy of glucocorticoids in treating patients with HSE remains controversial. This study aims to evaluate the effectiveness of glucocorticoids in patients with HSE and analyze the clinical characteristics of this patient population.
Methods: This retrospective study evaluated the clinical characteristics, auxiliary examinations, and patient prognosis of HSE patients diagnosed with mNGS, and analyzed the prognosis of patients in both Glucocorticoid and Non-glucocorticoid groups. Assess the prognosis based on the improvement of GOS score and MMSE score at 1 and 3 months after discharge.
Results: A retrospective analysis was conducted in 29 hSE patients who met the criteria for GOS score improvement 3 months after discharge. The hormone group was better than the non-hormone group (2 (0-2) scores VS 1 (1-2) scores). There was no significant difference between the two groups in GOS score 1 month after discharge. However, no statistical difference was found in improving patient outcomes between the two groups.
Conclusion: Despite the hormone group not obtaining the anticipated positive outcomes, potentially due to the relatively limited sample size in this study, previous case series reports have indicated that glucocorticoids, when used as an adjunct to acyclovir therapy, may enhance patient outcomes. Consequently, further extensive clinical studies involving multiple centers and larger sample sizes are warranted to investigate this matter further.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890644 | PMC |
| http://dx.doi.org/10.2147/IDR.S501628 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Outcomes of Hypertonic Saline vs Mannitol Treatment Among Children With Traumatic Brain Injury.
JAMA Netw Open
March 2025
Children's Intensive Care Unit, SingHealth Paediatrics Academic Clinical Programme, KK Women's and Children's Hospital, Singapore.
Importance: The use of hypertonic saline (HTS) vs mannitol in the control of elevated intracranial pressure (ICP) secondary to neurotrauma is debated.
Objective: To compare mortality and functional outcomes of treatment with 3% HTS vs 20% mannitol among children with moderate to severe traumatic brain injury (TBI) at risk of elevated ICP.
Design, Setting, And Participants: This prospective, multicenter cohort study was conducted between June 1, 2018, and December 31, 2022, at 28 participating pediatric intensive care units in the Pediatric Acute and Critical Care Medicine in Asia Network (PACCMAN) and the Red Colaborativa Pediátrica de Latinoamérica (LARed) in Asia, Latin America, and Europe.
Are Glucocorticoids Truly Effective in Improving the Clinical Prognosis of HSV-1 Encephalitis?
Infect Drug Resist
March 2025
Department of Neurology, Ganzhou People's Hospital, Jiangxi, 341000, People's Republic of China.
Background: Survivors of herpes simplex encephalitis (HSE) commonly experience significant neurological sequelae, imposing a substantial burden on both society and families. The efficacy of glucocorticoids in treating patients with HSE remains controversial. This study aims to evaluate the effectiveness of glucocorticoids in patients with HSE and analyze the clinical characteristics of this patient population.
View Article and Find Full Text PDFPredictors of poor outcomes in patients with traumatic brain injury at the University Teaching Hospital of Bamenda, Cameroon.
Clin Neurol Neurosurg
February 2025
Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon; Neurosurgery Department, Yaounde General and Central Hospitals, Yaounde, Cameroon. Electronic address:
Objective: This study aimed to determine the various predictors associated to poor outcomes in patients with traumatic brain injury at the University Teaching Hospital of Bamenda, Cameroon.
Methods: This descriptive and observational study was conducted at the University Teaching Hospital of Bamenda, Cameroon from February 1st 2023 to May 31st 2023. We included all patients managed for TBI in the named hospital within the study period who gave their consent.
Hyperbaric Oxygen Therapy (HBOT) in Moderate Traumatic Brain Injury (TBI): A Randomized Controlled Trial.
Asian J Neurosurg
March 2025
Department of Neurosurgery, National Institute of Mental Health and Neuro-Sciences, Bangalore, Karnataka, India.
Hyperbaric oxygen therapy (HBOT) is a novel technique recently under investigation with intention to improve outcomes in traumatic brain injury (TBI). It increases the partial pressure of oxygen in the blood and tissues by inhaling pure oxygen in an environment pressurized to at least 1.4 times normal atmospheric pressure (ATM) at sea level.
View Article and Find Full Text PDFBackground: Low-and middle-income countries bear a disproportionate burden of traumatic brain injury (TBI), with significant consequences for affected individuals and health systems. However, evidence on the incidence, risk factors, and associated vulnerability-particularly from road traffic injuries (RTIs)-remains limited in South Asia, including Bangladesh, which has one of the highest RTI burdens globally. This study aimed to investigate the epidemiology, clinical characteristics, health outcomes of TBI, and the vulnerability and risk factors associated with RTI-related TBI in Bangladesh.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!